BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 34375482)

  • 1. Tumor-associated macrophage-derived transforming growth factor-β promotes colorectal cancer progression through HIF1-TRIB3 signaling.
    Liu C; Zhang W; Wang J; Si T; Xing W
    Cancer Sci; 2021 Oct; 112(10):4198-4207. PubMed ID: 34375482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
    Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
    Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRIB3 promotes lung cancer progression by activating β-catenin signaling.
    Zhang X; Zhong N; Li X; Chen MB
    Eur J Pharmacol; 2019 Nov; 863():172697. PubMed ID: 31562867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRIB3 Promotes the Proliferation and Invasion of Renal Cell Carcinoma Cells via Activating MAPK Signaling Pathway.
    Hong B; Zhou J; Ma K; Zhang J; Xie H; Zhang K; Li L; Cai L; Zhang N; Zhang Z; Gong K
    Int J Biol Sci; 2019; 15(3):587-597. PubMed ID: 30745845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia promotes glioma-associated macrophage infiltration via periostin and subsequent M2 polarization by upregulating TGF-beta and M-CSFR.
    Guo X; Xue H; Shao Q; Wang J; Guo X; Chen X; Zhang J; Xu S; Li T; Zhang P; Gao X; Qiu W; Liu Q; Li G
    Oncotarget; 2016 Dec; 7(49):80521-80542. PubMed ID: 27602954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-Associated Macrophages Derived TGF-β‒Induced Epithelial to Mesenchymal Transition in Colorectal Cancer Cells through Smad2,3-4/Snail Signaling Pathway.
    Cai J; Xia L; Li J; Ni S; Song H; Wu X
    Cancer Res Treat; 2019 Jan; 51(1):252-266. PubMed ID: 29690747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRIB3 confers glioma cell stemness via interacting with β-catenin.
    Lu Y; Li L; Chen L; Gao Y; Chen X; Cao Y
    Environ Toxicol; 2020 Jun; 35(6):697-706. PubMed ID: 31995275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CPEB3 inhibits epithelial-mesenchymal transition by disrupting the crosstalk between colorectal cancer cells and tumor-associated macrophages via IL-6R/STAT3 signaling.
    Zhong Q; Fang Y; Lai Q; Wang S; He C; Li A; Liu S; Yan Q
    J Exp Clin Cancer Res; 2020 Jul; 39(1):132. PubMed ID: 32653013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRIB3 promotes proliferation, migration, and invasion of retinoblastoma cells by activating the AKT/mTOR signaling pathway.
    Bao XY; Sun M; Peng TT; Han DM
    Cancer Biomark; 2021; 31(4):307-315. PubMed ID: 33896816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRIB3 enhances cell viability during glucose deprivation in HEK293-derived cells by upregulating IGFBP2, a novel nutrient deficiency survival factor.
    Örd T; Örd D; Adler P; Vilo J; Örd T
    Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2492-505. PubMed ID: 26094770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of tribbles homolog 3 predicts poor prognosis and correlates with tumor immunity in clear cell renal cell carcinoma: a bioinformatics study.
    Wu XQ; Tian X; Xu FJ; Wang Y; Xu WH; Su JQ; Qu YY; Zhao JY; Zhang HL; Ye DW
    Bioengineered; 2022 May; 13(5):14000-14012. PubMed ID: 35726370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRIB3 Promotes APL Progression through Stabilization of the Oncoprotein PML-RARα and Inhibition of p53-Mediated Senescence.
    Li K; Wang F; Cao WB; Lv XX; Hua F; Cui B; Yu JJ; Zhang XW; Shang S; Liu SS; Yu JM; Han MZ; Huang B; Zhang TT; Li X; Jiang JD; Hu ZW
    Cancer Cell; 2017 May; 31(5):697-710.e7. PubMed ID: 28486108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt5a-induced M2 polarization of tumor-associated macrophages via IL-10 promotes colorectal cancer progression.
    Liu Q; Yang C; Wang S; Shi D; Wei C; Song J; Lin X; Dou R; Bai J; Xiang Z; Huang S; Liu K; Xiong B
    Cell Commun Signal; 2020 Mar; 18(1):51. PubMed ID: 32228612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DCLK1 integrates induction of TRIB3, EMT, drug resistance and poor prognosis in colorectal cancer.
    Makino S; Takahashi H; Okuzaki D; Miyoshi N; Haraguchi N; Hata T; Matsuda C; Yamamoto H; Mizushima T; Mori M; Doki Y
    Carcinogenesis; 2020 May; 41(3):303-312. PubMed ID: 31562741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of TRIB3 disrupts the tumor progression induced by integrin αvβ3 in lung cancer.
    Zhou W; Ma J; Meng L; Liu D; Chen J
    BMC Cancer; 2022 Apr; 22(1):459. PubMed ID: 35473511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disrupting the TRIB3-SQSTM1 interaction reduces liver fibrosis by restoring autophagy and suppressing exosome-mediated HSC activation.
    Zhang XW; Zhou JC; Peng D; Hua F; Li K; Yu JJ; Lv XX; Cui B; Liu SS; Yu JM; Wang F; Jin CC; Yang ZN; Zhao CX; Hou XY; Huang B; Hu ZW
    Autophagy; 2020 May; 16(5):782-796. PubMed ID: 31286822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRIB3 promotes hepatocellular carcinoma growth and predicts poor prognosis.
    Wang XJ; Li FF; Zhang YJ; Jiang M; Ren WH
    Cancer Biomark; 2020; 29(3):307-315. PubMed ID: 32716348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tribbles homolog 3 denotes a poor prognosis in breast cancer and is involved in hypoxia response.
    Wennemers M; Bussink J; Scheijen B; Nagtegaal ID; van Laarhoven HW; Raleigh JA; Varia MA; Heuvel JJ; Rouschop KM; Sweep FC; Span PN
    Breast Cancer Res; 2011 Aug; 13(4):R82. PubMed ID: 21864376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIF1α promotes tumor chemoresistance via recruiting GDF15-producing TAMs in colorectal cancer.
    Zheng H; Yu S; Zhu C; Guo T; Liu F; Xu Y
    Exp Cell Res; 2021 Jan; 398(2):112394. PubMed ID: 33242463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emodin induces apoptosis of lung cancer cells through ER stress and the TRIB3/NF-κB pathway.
    Su J; Yan Y; Qu J; Xue X; Liu Z; Cai H
    Oncol Rep; 2017 Mar; 37(3):1565-1572. PubMed ID: 28184934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.